Gifts to MIT and Harvard Medical School totaling $9 million will fund independent research on cannabinoid’s influence on brain health and behavior.
Finding could improve development of personalized psychiatric treatments.
MIT affiliates recognized for their innovative approaches to energy storage and drug discovery.
In talks at MIT, noted behavioral expert suggests encouraging skills of people with autism.
Discovery could lead to new treatments for cognitive disorders including autism and schizophrenia.
$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research
Transformative partnership with Ted Stanley will spur researchers to reveal biology of psychiatric disorders.